Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
File photo
An India-born virologist at Australian Centre for Disease Preparedness (ACDP) at Geelong, a port city southwest of Melbourne, is heading preclinical animal tests of Covid-19 vaccines.
SS Vasan, who leads the Dangerous Pathogens team at ACDP, which is a part of Australian national research agency, the Commonwealth Scientific and Industrial Research Organisation, is heading the team that will carry out animal studies on different vaccines against SARS-CoV2, which causes Covid-19 infection.
A team led by Vasan, senior principal research consultant for Health and Biosecurity at CSIRO, had earlier shown that ferrets – the domesticated European polecats – could be used as animal models to test the efficacy of vaccines and therapies against SARS-CoV2. This is because ferrets share lung physiology similar to humans’ and can thus be infected by the deadly virus which has so far caused over 1.28 million cases and killed more than 70,000 people worldwide.
As of now, the team led by Vasan, who also holds an honorary chair in Health Sciences at the University of York in the UK, will test two candidate vaccines being developed with funding from The Coalition for Epidemic Preparedness Innovations (CEPI), a foundation that takes donations from philanthropic, and civil society organisations to support independent vaccine projects.
CEPI has so far extended funding to eight potential Covid-19 vaccines. One CEPI-funded vaccine, developed by a US firm called Moderna, entered human trials in March. Significantly, the vice-chair of CEPI is Gagandeep Kang, Executive Director of the Translational Health Science and Technology Institute at Faridabad.
Among the two vaccines being tested on ferrets, one is a DNA vaccine, INO-4800, developed by the US-based pharma firm Inovio and Beijing Advaccine, and the other one is from an Oxford University team. While the Oxford vaccine is said to be intramuscular, Vasan’s team will be testing its efficacy as intranasal as well.
“This is because I want to find out if intranasal administration will confer mucosal immunity so the vaccine will be more protective with just a single dose,” Vasan told BusinessLine from Geelong.
Both these vaccines are scheduled to enter Phase-I clinical trials with healthy volunteers. “Looking at the urgency of the situation, vaccine developers are conducting animal studies simultaneously,” Vasan said.
Recently, the Australian government announced an additional $220 million to CSIRO bio-security research facility in Geelong so that the infrastructure can be beefed up to handle deadly viruses such as SARS-CoV2 and test potential vaccines. The preclinical research by Vasan's team is funded by a partnership between CSIRO and CEPI.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
Will a stock continue its current trend or will it reverse? We tell you how you can read chart patterns to ...
₹1483 • HDFC Bank S1S2R1R2COMMENT 1465145015001510 Fresh short positions can be initiated with stop-loss at ...
Bucking the overall market trend, the stock of Capri Global Capital Limited (CGCL) gained on Monday and ...
Most AMCs have been sending out cryptic e-mails. We tell you how to read between the lines
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
On the eve of his 86th birthday, a peek into an interview-based book that reveals the actor’s many moods, ...
Forget the tuna. The island nation will keep you full and happy with coconut, koftas and jasmine
This year, on Facebook, I saw that someone had posted a list of EASY RESOLUTIONS. I didn’t copy them down but ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor